126 related articles for article (PubMed ID: 25215555)
1. Low-dose calcium versus pentagastrin for stimulation of calcitonin in chronic hemodialysis patients: a pilot study.
Thiem U; Marculescu R; Cejka D; Gessl A; Borchhardt K
J Clin Endocrinol Metab; 2014 Dec; 99(12):4704-11. PubMed ID: 25215555
[TBL] [Abstract][Full Text] [Related]
2. Calcitonin concentrations in patients with chronic kidney disease and medullary thyroid carcinoma or c-cell hyperplasia.
Borchhardt KA; Heinzl H; Gessl A; Hörl WH; Kaserer K; Sunder-Plassmann G
Kidney Int; 2006 Dec; 70(11):2014-20. PubMed ID: 17051143
[TBL] [Abstract][Full Text] [Related]
3. Basal calcitonin levels and the response to pentagastrin stimulation in patients after kidney transplantation or on chronic hemodialysis as indicators of medullary carcinoma.
Kotzmann H; Schmidt A; Scheuba C; Kaserer K; Watschinger B; Söregi G; Niederle B; Vierhapper H
Thyroid; 1999 Sep; 9(9):943-7. PubMed ID: 10524574
[TBL] [Abstract][Full Text] [Related]
4. Calcium infusion and pentagastrin injection in diagnosis of medullary thyroid carcinoma.
Verdy M; Cholette JP; Cantin J; Lacroix A; Sturtridge WC
Can Med Assoc J; 1978 Jul; 119(1):29-35. PubMed ID: 679097
[TBL] [Abstract][Full Text] [Related]
5. Pre- and postoperative studies of plasma calcitonin in primary hyperparathyroidism.
Lambert PW; Heath H; Sizemore GW
J Clin Invest; 1979 Apr; 63(4):602-8. PubMed ID: 438324
[TBL] [Abstract][Full Text] [Related]
6. Abnormal calcitonin basal levels and pentagastrin response in patients with chronic renal failure on maintenance hemodialysis.
Niccoli P; Brunet P; Roubicek C; Roux F; Baudin E; Lejeune PJ; Berland Y; Conte-Devolx B
Eur J Endocrinol; 1995 Jan; 132(1):75-81. PubMed ID: 7850012
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A
Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
[TBL] [Abstract][Full Text] [Related]
8. Potency and tolerance of calcitonin stimulation with high-dose calcium versus pentagastrin in normal adults.
Doyle P; Düren C; Nerlich K; Verburg FA; Grelle I; Jahn H; Fassnacht M; Mäder U; Reiners C; Luster M
J Clin Endocrinol Metab; 2009 Aug; 94(8):2970-4. PubMed ID: 19491231
[TBL] [Abstract][Full Text] [Related]
9. Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer.
Colombo C; Verga U; Mian C; Ferrero S; Perrino M; Vicentini L; Dazzi D; Opocher G; Pelizzo MR; Beck-Peccoz P; Fugazzola L
J Clin Endocrinol Metab; 2012 Mar; 97(3):905-13. PubMed ID: 22170709
[TBL] [Abstract][Full Text] [Related]
10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic evaluation of measurements of carboxyl-terminal flanking peptide (PDN-21) of the human calcitonin gene in human serum.
Ittner J; Dambacher MA; Born W; Ketelslegers JM; Buysschaert M; Albert PM; Lambert AE; Fischer JA
J Clin Endocrinol Metab; 1985 Dec; 61(6):1133-7. PubMed ID: 3902867
[TBL] [Abstract][Full Text] [Related]
12. Calcitonin concentrations in patients with chronic kidney disease on hemodialysis in reference to parathyroidectomy.
Sabia R; Wagner M; Susa K; Lemke J; Rothermund L; Henne-Bruns D; Hillenbrand A
BMC Res Notes; 2019 Jul; 12(1):439. PubMed ID: 31324271
[TBL] [Abstract][Full Text] [Related]
13. Pentagastrin testing in patients with renal insufficiency: normal responsivity of mature calcitonin.
Lissak B; Baudin E; Cohen R; Barbot N; Meyrier A; Niccoli P; Bouyge N; Modigliani E
Thyroid; 1998 Mar; 8(3):265-8. PubMed ID: 9545114
[TBL] [Abstract][Full Text] [Related]
14. Comparison of serum calcitonin levels after a 1-minute calcium injection and after pentagastrin injection in the diagnosis of medullary thyroid carcinoma.
Rude RK; Singer FR
J Clin Endocrinol Metab; 1977 May; 44(5):980-3. PubMed ID: 858780
[TBL] [Abstract][Full Text] [Related]
15. Intravenous 1,25(OH)2D therapy increases the intact parathyroid hormone secretion set point in hemodialyzed patients.
Brossard JH; Roy L; Lepage R; Gascon-Barré M; D'Amour P
Miner Electrolyte Metab; 1997; 23(1):25-32. PubMed ID: 9058366
[TBL] [Abstract][Full Text] [Related]
16. Medullary thyroid cancer responsiveness to pentagastrin stimulation: an early surrogate parameter of tumor dissemination?
Machens A; Hauptmann S; Dralle H
J Clin Endocrinol Metab; 2008 Jun; 93(6):2234-8. PubMed ID: 18364379
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules.
Costante G; Meringolo D; Durante C; Bianchi D; Nocera M; Tumino S; Crocetti U; Attard M; Maranghi M; Torlontano M; Filetti S
J Clin Endocrinol Metab; 2007 Feb; 92(2):450-5. PubMed ID: 17119000
[TBL] [Abstract][Full Text] [Related]
18. A comparison of pentagastrin injection and calcium infusion as provocative agents for the detection of medullary carcinoma of the thyroid.
Hennessy JF; Wells SA; Ontjes DA; Cooper CW
J Clin Endocrinol Metab; 1974 Sep; 39(3):487-95. PubMed ID: 4471967
[No Abstract] [Full Text] [Related]
19. Identification of occult metastases of medullary thyroid carcinoma by pentagastrin-stimulated intravenous calcitonin sampling followed by targeted surgery.
Schott M; Willenberg HS; Sagert C; Nguyen TB; Schinner S; Cohnen M; Cupisti K; Eisenberger CF; Knoefel WT; Scherbaum WA
Clin Endocrinol (Oxf); 2007 Mar; 66(3):405-9. PubMed ID: 17302876
[TBL] [Abstract][Full Text] [Related]
20. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC
J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
